This inventor holds 1 USPTO granted patent. Top assignee: Ohta Seiyaku Kabushiki Kaisha. Active years: 1986.
Company Filing History:
Years Active: 1986
Title: The Innovations of Saburo Sugai
Introduction
Saburo Sugai is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory drugs. His work has led to advancements that benefit patients suffering from various dermal disorders and allergic diseases.
Latest Patents
One of Saburo Sugai's key patents is for a compound known as 6.alpha.-Methylprednisolone derivatives. This compound is characterized by a general formula that includes specific alkyl and phenyl groups. It exhibits a strong local anti-inflammatory effect, making it useful as a harmless external anti-inflammatory drug. Additionally, it serves as an antiallergic drug for treating asthma and other allergic diseases. This patent highlights his innovative approach to addressing medical challenges.
Career Highlights
Saburo Sugai is associated with Ohta Seiyaku Kabushiki Kaisha, a company that focuses on pharmaceutical development. His work at this organization has allowed him to explore and develop new therapeutic solutions. With a total of 1 patent, Sugai has established himself as a valuable contributor to the field of medicine.
Collaborations
Throughout his career, Saburo Sugai has collaborated with notable colleagues, including Yoshiaki Kamano and Tokuji Okazaki. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in the pharmaceutical industry.
Conclusion
In summary, Saburo Sugai's contributions to the field of pharmaceuticals, particularly through his patent for 6.alpha.-Methylprednisolone derivatives, demonstrate his commitment to improving healthcare. His work continues to have a positive impact on the treatment of various medical conditions.